Hepatology - European Medical Journal

Continue

Hepatology

Filter
2 Mins
28 May 2019

L-carnitine Could Be Beneficial in Nonalcoholic Fatty Liver Disease Patients by Improving Choline Metabolism and Reducing Liver Biomarkers

This study investigated what effect L-carnitine supplementation could have on liver metabolites. In this study, the authors hypothesised that L-carnitine…
3 Mins
28 May 2019

miRNA-21 Ablation in Mice Protects Against Gut Microbiota Dysbiosis During Cholestasis

Gut microbiota play an important role in gut–liver axis homeostasis. The understanding of the gut–liver relationship is crucial for the advances of…
1 Mins
28 May 2019

The Good Use of Paracetamol: Prospective Assessment of the Knowledge of Prescribers, Pharmacists, Care Providers, and Students in a University Medical Centre

The knowledge regarding the proper use of paracetamol is insufficient for the maximum chronic dosage, the risk of paracetamol hepatotoxicity…
2 Mins
28 May 2019

Neutrophil-to-Lymphocyte Ratio and Corticosteroid Response in Alcoholic Hepatitis

Treatment of alcoholic hepatitis with corticosteroids remains controversial, with recent studies indicating only a 28-day survival benefit…
1 Mins
31 May 2018

Resolution of Ascites, Hepatic Encephalopathy, and Variceal Bleeding in Patients with Hepatitis C Virus and Decompensated Cirrhosis Who Received All-Oral Direct-Acting Antiviral Treatment

Worldwide, 185 million people are infected with the hepatitis C virus (HCV);1 approximately 12% of these individuals have manifestations of decompensated…
1 Mins
31 May 2018

A Comparison of Renal Function Before and After Treatment of Chronic Hepatitis C Infection in Patients Who Achieve Sustained Virological Response with Direct-Acting Antivirals

Approximately 3 million people have chronic hepatitis C virus (HCV) infection in the USA. However, there are limited data with regard to the effect of…
2 Mins
31 May 2018

OPTIMIS: Real-World Data in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolisation: Second Interim Analysis

Transarterial chemoembolisation (TACE) is the most common treatment modality for hepatocellular carcinoma (HCC) worldwide, often used to treat cases…
2 Mins
31 May 2018

Acute Liver Failure: Time to Review Our Follow-Up Policy?

Acute liver failure (ALF) is a rare but serious clinical condition resulting from sudden, massive loss of hepatic parenchyma and metabolic functions.